337 related articles for article (PubMed ID: 30445705)
1. Evaluation of β-Sitosterol Loaded PLGA and PEG-PLA Nanoparticles for Effective Treatment of Breast Cancer: Preparation, Physicochemical Characterization, and Antitumor Activity.
Andima M; Costabile G; Isert L; Ndakala AJ; Derese S; Merkel OM
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30445705
[TBL] [Abstract][Full Text] [Related]
2. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
Liu D; Wang L; Liu Z; Zhang C; Zhang N
J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
5. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.
Zhang J; Li Y; Gao W; Repka MA; Wang Y; Chen M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1367-80. PubMed ID: 24935153
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Characterization of PLA-PEG-PLA/PEI/DNA Nanoparticles for Improvement of Transfection Efficiency and Controlled Release of DNA in Gene Delivery Systems.
Amani A; Kabiri T; Shafiee S; Hamidi A
Iran J Pharm Res; 2019; 18(1):125-141. PubMed ID: 31089350
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
Chen J; Li S; Shen Q; He H; Zhang Y
Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
[TBL] [Abstract][Full Text] [Related]
8. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
Essa S; Louhichi F; Raymond M; Hildgen P
J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
[TBL] [Abstract][Full Text] [Related]
9. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
11. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
Devulapally R; Sekar TV; Paulmurugan R
Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).
Cruz J; Flórez J; Torres R; Urquiza M; Gutiérrez JA; Guzmán F; Ortiz CC
Nanotechnology; 2017 Mar; 28(13):135102. PubMed ID: 28266350
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity.
Pieper S; Onafuye H; Mulac D; Cinatl J; Wass MN; Michaelis M; Langer K
Beilstein J Nanotechnol; 2019; 10():2062-2072. PubMed ID: 31728254
[No Abstract] [Full Text] [Related]
15. Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA.
Zou W; Liu C; Chen Z; Zhang N
Nanoscale Res Lett; 2009 May; 4(9):982-992. PubMed ID: 20596550
[TBL] [Abstract][Full Text] [Related]
16. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel-loaded PLGA nanoparticles to increase pharmacological sensitivity in MDA-MB-231 and MCF-7 breast cancer cells.
Tran P; Nguyen TN; Lee Y; Tran PN; Park JS
Korean J Physiol Pharmacol; 2021 Sep; 25(5):479-488. PubMed ID: 34448465
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of three-arm block copolymer poly(lactic-
Zhu X; Liu C; Duan J; Liang X; Li X; Sun H; Kong D; Yang J
Int J Nanomedicine; 2016; 11():6065-6077. PubMed ID: 27895480
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate cancer cells.
Wang K; Guo L; Xiong W; Sun L; Zheng Y
J Biomater Appl; 2014 Sep; 29(3):329-40. PubMed ID: 24621530
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG.
Haggag Y; Abdel-Wahab Y; Ojo O; Osman M; El-Gizawy S; El-Tanani M; Faheem A; McCarron P
Int J Pharm; 2016 Feb; 499(1-2):236-246. PubMed ID: 26746800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
